Axis Bank’s Q3FY26 performance marks a return to earnings normalcy, free of one-off distortions, even as margin pressures persist in a shifting rate environment.
Coforge Limited delivered a mixed operational performance in Q3FY26, missing revenue and profitability estimates, yet reinforcing its long-term investment thesis through a sharply expanding order b
DLF's Q3FY26 performance may appear underwhelming at first glance, but a deeper examination suggests that the company’s long-term growth trajectory remains firmly intact.
Axis Securities has reiterated its BUY call on Kotak Mahindra Bank Limited, assigning a target price of Rs 515, implying an upside of 22% from current levels.
Dr Reddy’s Laboratories is navigating a critical transition phase as legacy gains from gRevlimid taper off, even as the company lays the groundwork for its next multi-year growth cycle.
